391 related articles for article (PubMed ID: 29699987)
1. Decreased expression of A20 is associated with ocular Behcet's disease (BD) but not with Vogt-Koyanagi-Harada (VKH) disease.
He Y; Wang C; Su G; Deng B; Ye Z; Huang Y; Yuan G; Aize K; Li H; Yang P
Br J Ophthalmol; 2018 Aug; 102(8):1167-1172. PubMed ID: 29699987
[TBL] [Abstract][Full Text] [Related]
2. Decreased microRNA-155 expression in ocular Behcet's disease but not in Vogt Koyanagi Harada syndrome.
Zhou Q; Xiao X; Wang C; Zhang X; Li F; Zhou Y; Kijlstra A; Yang P
Invest Ophthalmol Vis Sci; 2012 Aug; 53(9):5665-74. PubMed ID: 22815348
[TBL] [Abstract][Full Text] [Related]
3. Higher Expression of NOD1 and NOD2 is Associated with Vogt-Koyanagi-Harada (VKH) Syndrome But Not Behcet's Disease (BD).
Deng B; Ye Z; Li L; Zhang D; Zhu Y; He Y; Wang C; Wu L; Kijlstra A; Yang P
Curr Mol Med; 2016; 16(4):424-35. PubMed ID: 26980698
[TBL] [Abstract][Full Text] [Related]
4. Disabled-2 (DAB2) Overexpression Inhibits Monocyte-Derived Dendritic Cells' Function in Vogt-Koyanagi-Harada Disease.
Yi S; Chang R; Hu J; Qiu Y; Wang Q; Cao Q; Yuan G; Su G; Zhou C; Wang Y; Kijlstra A; Yang P
Invest Ophthalmol Vis Sci; 2018 Sep; 59(11):4662-4669. PubMed ID: 30267088
[TBL] [Abstract][Full Text] [Related]
5. A possible role for interleukin 37 in the pathogenesis of Behcet's disease.
Ye Z; Wang C; Kijlstra A; Zhou X; Yang P
Curr Mol Med; 2014 May; 14(4):535-42. PubMed ID: 24730521
[TBL] [Abstract][Full Text] [Related]
6. Expression and role of interleukin-9 in Vogt-Koyanagi-Harada disease.
Peng Z; Jiang S; Wu M; Zhou X; Wang Q
Mol Vis; 2017; 23():538-547. PubMed ID: 28761327
[TBL] [Abstract][Full Text] [Related]
7. miR-23a, miR-146a and miR-301a confer predisposition to Vogt-Koyanagi-Harada syndrome but not to Behcet's disease.
Hou S; Ye Z; Liao D; Bai L; Liu Y; Zhang J; Kijlstra A; Yang P
Sci Rep; 2016 Jan; 6():20057. PubMed ID: 26818976
[TBL] [Abstract][Full Text] [Related]
8. The Rs12569232 SNP Association with Vogt-Koyanagi-Harada Disease and Behcet's Disease is Probably Mediated by Regulation of Linc00467 Expression.
Wang Q; Yi S; Du Z; Huang X; Xu J; Cao Q; Su G; Kijlstra A; Yang P
Ocul Immunol Inflamm; 2021 Nov; 29(7-8):1464-1470. PubMed ID: 32400232
[No Abstract] [Full Text] [Related]
9. Association of Long Noncoding RNAs Polymorphisms With Ankylosing Spondylitis, Vogt-Koyanagi-Harada Disease, and Behcet's Disease.
Yue Y; Zhang J; Yang L; Liu S; Qi J; Cao Q; Zhou C; Wang Y; Kijlstra A; Yang P; Hou S
Invest Ophthalmol Vis Sci; 2018 Feb; 59(2):1158-1166. PubMed ID: 29490353
[TBL] [Abstract][Full Text] [Related]
10. Increased Complement 3a Receptor is Associated with Behcet's disease and Vogt-Koyanagi-Harada disease.
Wang C; Cao S; Zhang D; Li H; Kijlstra A; Yang P
Sci Rep; 2017 Nov; 7(1):15579. PubMed ID: 29138505
[TBL] [Abstract][Full Text] [Related]
11. Decreased interleukin 27 expression is associated with active uveitis in Behçet's disease.
Wang C; Tian Y; Ye Z; Kijlstra A; Zhou Y; Yang P
Arthritis Res Ther; 2014 May; 16(3):R117. PubMed ID: 24887071
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-146a and Ets-1 gene polymorphisms in ocular Behcet's disease and Vogt-Koyanagi-Harada syndrome.
Zhou Q; Hou S; Liang L; Li X; Tan X; Wei L; Lei B; Kijlstra A; Yang P
Ann Rheum Dis; 2014 Jan; 73(1):170-6. PubMed ID: 23268366
[TBL] [Abstract][Full Text] [Related]
13. TRAF5 and TRAF3IP2 gene polymorphisms are associated with Behçet's disease and Vogt-Koyanagi-Harada syndrome: a case-control study.
Xiang Q; Chen L; Hou S; Fang J; Zhou Y; Bai L; Liu Y; Kijlstra A; Yang P
PLoS One; 2014; 9(1):e84214. PubMed ID: 24416204
[TBL] [Abstract][Full Text] [Related]
14. Increased Expression of IL-23 Receptor (IL-23R) in Vogt-Koyanagi-Harada (VKH) Disease.
Wang C; Wang L; Hu J; Li H; Kijlstra A; Yang P
Curr Eye Res; 2018 Nov; 43(11):1369-1373. PubMed ID: 29877734
[TBL] [Abstract][Full Text] [Related]
15. Association of TLR2 gene polymorphisms with ocular Behcet's disease in a Chinese Han population.
Fang J; Hu R; Hou S; Ye Z; Xiang Q; Qi J; Zhou Y; Kijlstra A; Yang P
Invest Ophthalmol Vis Sci; 2013 Dec; 54(13):8384-92. PubMed ID: 24255044
[TBL] [Abstract][Full Text] [Related]
16. Decreased IL-27 expression in association with an increased Th17 response in Vogt-Koyanagi-Harada disease.
Wang C; Tian Y; Lei B; Xiao X; Ye Z; Li F; Kijlstra A; Yang P
Invest Ophthalmol Vis Sci; 2012 Jul; 53(8):4668-75. PubMed ID: 22669715
[TBL] [Abstract][Full Text] [Related]
17. Copy number variations and gene polymorphisms of complement components in ocular Behcet's disease and Vogt-Koyanagi-Harada syndrome.
Xu D; Hou S; Zhang J; Jiang Y; Kijlstra A; Yang P
Sci Rep; 2015 Aug; 5():12989. PubMed ID: 26269006
[TBL] [Abstract][Full Text] [Related]
18. Upregulation of interleukin 21 and promotion of interleukin 17 production in chronic or recurrent Vogt-Koyanagi-Harada disease.
Li F; Yang P; Liu X; Wang C; Hou S; Kijlstra A
Arch Ophthalmol; 2010 Nov; 128(11):1449-54. PubMed ID: 21060047
[TBL] [Abstract][Full Text] [Related]
19. Decreased interleukin(IL)-35 Expression is Associated with Active Intraocular Inflammation in Vogt-Koyanagi-Harada (VKH) Disease.
Hu J; Qin Y; Yi S; Wang C; Yang J; Yang L; Wang L; Kijlstra A; Yang P; Li H
Ocul Immunol Inflamm; 2019; 27(4):595-601. PubMed ID: 29498905
[No Abstract] [Full Text] [Related]
20. Decreased interleukin-37 expression in Vogt-Koyanagi-Harada disease and upregulation following immunosuppressive treatment.
Ye Z; Wang C; Tang J; Zhou Y; Bai L; Liu Y; Kijlstra A; Yang P
J Interferon Cytokine Res; 2015 Apr; 35(4):265-72. PubMed ID: 25343528
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
